Header Logo

Connection

HESHAM MOHAMED to Fusion Proteins, bcr-abl

Back to Details
This is a "connection" page, showing publications HESHAM MOHAMED has written about Fusion Proteins, bcr-abl.
HESHAM MOHAMED
Connection Strength
0.028
Fusion Proteins, bcr-abl
  1. Long-term outcome with dasatinib after imatinib failure in chronic-phase chronic myeloid leukemia: follow-up of a phase 3 study. Blood. 2014 Apr 10; 123(15):2317-24.
    View in: PubMed
    Score: 0.028
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.